David Kyle
Physician Assistant · Reno, NVNPI 1235820747
Payments from drug & device makers
Across 282 payments — averaging $19.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$909
- AbbVie$763
- Neurocrine Biosciences, Inc.$397
- Pfizer$372
- Bristol Myers Squibb$368
- Lundbeck LLC$333
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,440100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 51 | $909 |
| AbbVie | 42 | $763 |
| Neurocrine Biosciences, Inc. | 17 | $397 |
| Pfizer | 19 | $372 |
| Bristol Myers Squibb | 21 | $368 |
| Lundbeck LLC | 16 | $333 |
| Argenx US, Inc. | 15 | $296 |
| Biogen | 18 | $266 |
| Neurelis, Inc. | 12 | $221 |
| Catalyst Pharmaceuticals, Inc. | 6 | $129 |
| Teva Pharmaceuticals USA, Inc. | 5 | $120 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| AstraZeneca | 5 | $95 |
| Axsome Therapeutics, Inc. | 3 | $91 |
| ANI Pharmaceuticals, Inc. | 4 | $86 |
| MDD US Operations, LLC | 2 | $81 |
| Jazz Pharmaceuticals Inc. | 4 | $79 |
| Genentech USA, Inc. | 4 | $79 |
| CSL Behring | 4 | $74 |
| Vanda Pharmaceuticals Inc. | 4 | $70 |
| Scilex Pharmaceuticals Inc. | 3 | $68 |
| Amneal Pharmaceuticals LLC | 4 | $67 |
| Amgen | 3 | $60 |
| SK Life Science, Inc. | 2 | $51 |
| Boston Scientific | 1 | $39 |
| Cala Health, Inc. | 2 | $33 |
| Abbott | 2 | $32 |
| Microtransponder, Inc. | 1 | $24 |
| Novartis | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| Octapharma USA, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Livanova USA, Inc. | 1 | $16 |
| Grifols USA, LLC | 1 | $14 |
How this compares
$5,440 in reported general payments places this provider in the 90th percentile of 881 physician assistant providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 13 | $122,755 |
| EliquisApixaban | 35 | $46,433 |
| XcopriCenobamate | 11 | $20,000 |
| QuliptaAtogepant | 11 | $19,794 |
| Lacosamide | 54 | $11,293 |
| OngentysOpicapone | 11 | $10,563 |
| Baclofen | 144 | $7,026 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 132 | $5,333 |
| Memantine Hcl | 148 | $3,700 |
| Pyridostigmine Bromide | 16 | $3,099 |
| AmantadineAmantadine Hcl | 76 | $2,223 |
| Donepezil Hcl | 105 | $2,120 |
| Pregabalin | 24 | $2,117 |
| Gabapentin | 97 | $2,112 |
| Propranolol Hcl | 105 | $2,092 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza, Ongentys | $397 | $133,31724 claims |
| PfizerEliquis | $372 | $46,43335 claims |
| SK Life Science, Inc.Xcopri | $51 | $20,00011 claims |
| AbbVieQulipta | $763 | $19,79411 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide | $67 | $3,09916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 881 physician assistant providers in Nevada.
Other physician assistant in Reno
- John LarsenReno$49K
- Laura BiehleReno$36K
- Benjamin ProhaskaReno$31K
- Rebecca SparksReno$16K
- Daniel CollReno$12K
- Cameron WheelerReno$11K
- Julia WronaReno$10K
- Amber FrancoReno$9K
- Paul JohnsReno$8K
- Shannon WeaverReno$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.